{
  "docId": "019de516-48a5-7631-970d-a6192a59c040",
  "docSlug": "5b4cac48a3342d745accb48141e027b4",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 34,
  "pageCount": 39,
  "prevPage": 33,
  "nextPage": 35,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 100,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-48a5-7631-970d-a6192a59c040/34",
  "deckHref": "/decks/019de516-48a5-7631-970d-a6192a59c040",
  "deckJsonHref": "/decks/019de516-48a5-7631-970d-a6192a59c040.json",
  "deckAnchorHref": "/decks/019de516-48a5-7631-970d-a6192a59c040#slide-34",
  "components": [
    {
      "bbox": {
        "h": 0.025,
        "w": 0.109,
        "x": 0.04,
        "y": 0.944
      },
      "kind": "image",
      "text": "BAUSCH+LOMB",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d05a5df6-1f85-4c18-bacb-cbdcc36f3903",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.103,
        "w": 0.737,
        "x": 0.176,
        "y": 0.876
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or non-GAAP ratio. See Slide 1 and Non-GAAP Appendix for further information on non-GAAP measures and ratios.\n2. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.\n3. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3be0156c-e6a8-4da6-91f2-6e842cf60737",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.346,
        "w": 0.746,
        "x": 0.209,
        "y": 0.147
      },
      "kind": "table",
      "text": "Calculation of Constant Currency Revenue for the Three Months Ended June 30, 2023 and June 30, 2022, showing Revenue as Reported, Changes in Exchange Rates, Constant Currency Revenue (Non-GAAP), and Change in Reported Revenue and Constant Currency Revenue for Vision Care, Surgical, and Pharmaceuticals segments.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0248f482-eff5-449d-b255-aa5fe7a9f999",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.346,
        "w": 0.746,
        "x": 0.209,
        "y": 0.497
      },
      "kind": "table",
      "text": "Calculation of Constant Currency Revenue for the Six Months Ended June 30, 2023 and June 30, 2022, showing Revenue as Reported, Changes in Exchange Rates, Constant Currency Revenue (Non-GAAP), and Change in Reported Revenue and Constant Currency Revenue for Vision Care, Surgical, and Pharmaceuticals segments.",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1fa6628f-267b-4472-999f-fc854ebe706a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 14,
      "beatId": "83fb7e88-f765-459a-865d-12d458331d10",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The company outlines its plans for future growth and provides additional information.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}